Table 6 Antiviral activity of effective antibacterial isolates against SARS-CoV-2
Sample | Conc (CFU/ml) | Cytotoxicity % | Initial Viral count (PFU/ml) | Post Viral count (PFU/ml) | Inhibition % |
|---|---|---|---|---|---|
G2 | 10−4 | 72.51 | 8*104 | 2.42*104 | 69 |
10−5 | 69.74 | 4.91*104 | 38 | ||
10−6 | 54.13 | 5.62*104 | 29 | ||
10−7 | 44.99 | 7.41*104 | 7 | ||
R1 | 10−4 | 71.36 | 8*104 | 2.99*104 | 62 |
10−5 | 58.89 | 4.52*104 | 43 | ||
10−6 | 51.92 | 5.14*104 | 35 | ||
10−7 | 47.97 | 7.05*104 | 11 | ||
S6 | 10−4 | 68.12 | 8*104 | 3.02*104 | 62 |
10−5 | 61.41 | 4.23*104 | 47 | ||
10−6 | 50.85 | 5.66*104 | 29 | ||
10−7 | 48.42 | 7.39*104 | 7 |